Trial Profile
Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2014
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Migraine; Neuropathic pain; Partial epilepsies; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Bial
- 18 Sep 2013 New trial record